One hypothesis linking tobacco use with MPN includes the possibility that tobacco triggers a low-grade inflammatory state precipitating the development of myeloid mutations and thereby giving rise to MPN with the most critical phenotypic driver mutations being the JAK2V617-, CALR-, and MPL-mutations [11–13, 16]. The gene discussed is MPL; the disease is myeloproliferative neoplasm.